BM
Venture capital firm profile
BioVentures MedTech Funds
BioVentures MedTech Funds invests in emerging and growth-stage medical technology companies, providing capital, board participation and guidance for development, commercialization and exits.
Venture capital firm profile
BioVentures MedTech Funds invests in emerging and growth-stage medical technology companies, providing capital, board participation and guidance for development, commercialization and exits.
Growth
Typically leads financing and participates on boards. Growth strategy targets $10–25m in substantially de-risked development/regulatory businesses; innovation strategy targets $5–10m across multiple rounds/tranches. Currency not explicitly specified. Seeks meaningful clinical innovation, healthcare economics and acquirer alignment; no confidentiality agreement before initial investment interest.
Healthcare & Life Sciences
Typically leads financing and participates on boards. Growth strategy targets $10–25m in substantially de-risked development/regulatory businesses; innovation strategy targets $5–10m across multiple rounds/tranches. Currency not explicitly specified. Seeks meaningful clinical innovation, healthcare economics and acquirer alignment; no confidentiality agreement before initial investment interest.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
BioVentures MedTech Funds focuses on technologies that improve diagnosis, treatment and healthcare delivery economics. The team combines scientific, clinical, regulatory and operating experience with financing expertise. It supports companies through development and commercial growth while maintaining relationships with potential strategic acquirers.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-15
BioVentures MedTech Funds official sourceBioVentures MedTech Funds official sourceBioVentures MedTech Funds official sourceBioVentures MedTech Funds official sourceLoading recent changes…